Results 311 to 320 of about 132,013 (384)

Pulmonary function testing in pediatric allogeneic stem cell transplant recipients to monitor for Bronchiolitis obliterans syndrome: a systematic review. [PDF]

open access: yesBMC Pediatr
Gower WA   +15 more
europepmc   +1 more source

Preventing false spirometry values and invalid symptom scores in respiratory clinical trials*1

open access: bronze, 2004
Stephen A. Raymond   +3 more
openalex   +1 more source

Widening Patient Engagement for Rare Disease Drug Trials: The Perspectives of Patients With Idiopathic Pulmonary Fibrosis on Participating in Clinical Drug Trials and Drug Trial Design

open access: yesHealth Expectations, Volume 28, Issue 2, April 2025.
ABSTRACT Background Research about patient engagement for people with rare diseases has identified how the experiences of some members of the public are overlooked in relation to clinical trial design and trial participation. As part of a knowledge transfer partnership (KTP), the authors were granted access to patient insight reports about the needs of
Julia Frost   +6 more
wiley   +1 more source

Intra-breath respiratory mechanics of prematurity-associated lung disease phenotypes in school-aged children. [PDF]

open access: yesERJ Open Res
Cousins M   +6 more
europepmc   +1 more source

Assessment of Home-based Monitoring in Adults with Chronic Lung Disease: An Official American Thoracic Society Research Statement. [PDF]

open access: yesAm J Respir Crit Care Med
Khor YH   +31 more
europepmc   +1 more source

Respiratory safety of lemborexant in adult and elderly subjects with moderate‐to‐severe chronic obstructive pulmonary disease

open access: yesJournal of Sleep Research, Volume 34, Issue 2, April 2025.
Lemborexant 10 mg, a dual orexin‐receptor antagonist (DORA), did not elicit respiratory depressant effects, as measured by peripheral oxygen saturation (SpO2) or apnea–hypopnea index (AHI), in subjects with moderate‐to‐severe chronic obstructive pulmonary disease (COPD).
Jocelyn Y. Cheng   +3 more
wiley   +1 more source

The Impact of Age and Disease Entity on Small Airway Dysfunction in Obstructive Airway Diseases. [PDF]

open access: yesInt J Chron Obstruct Pulmon Dis
Li Y   +7 more
europepmc   +1 more source

Misdiagnosis of asthma and COPD and underuse of spirometry in primary care unselected patients.

open access: yesRespiratory Medicine, 2018
E. Heffler   +6 more
semanticscholar   +1 more source

Heterogeneity of reduced FEV1 in early adulthood: A looking forward, looking backwards analysis

open access: yesRespirology, Volume 30, Issue 4, Page 326-334, April 2025.
Abstract Background Some individuals never achieve normal peak FEV1 in early adulthood. It is unknown if this is due to airflow limitation and/or lung restriction. Methods To investigate this, we: (1) looked forward in 19,791 participants in the Dutch Lifelines general population cohort aged 25–35 years with 5‐year follow‐up; and (2) looked backwards ...
Nuria Olvera   +8 more
wiley   +1 more source

Association between e-cigarette exposure and ventilation homogeneity in young adults: a cross-sectional study. [PDF]

open access: yesEur Respir J
Stanojevic S   +8 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy